Single and Multiple Ascending Oral Doses of Avenanthramide
Condition(s):InflammationLast Updated:February 26, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):InflammationLast Updated:February 26, 2024Recruiting
Condition(s):Chronic Hepatitis CLast Updated:March 7, 2017Unknown status
Condition(s):Transient; Hypoglycemia, Neonatal; Preterm; Glibenclamide Adverse ReactionLast Updated:June 18, 2023Recruiting
Condition(s):Intermittent Fasting; Weight Loss; Behavioral Economic; Obese; HOMA-IRLast Updated:February 15, 2024Enrolling by invitation
Condition(s):Diabetes Mellitus, Type 2Last Updated:January 25, 2018Completed
Condition(s):Covid19Last Updated:February 10, 2022Terminated
Condition(s):Urinary Bladder, OveractiveLast Updated:November 27, 2020Completed
Condition(s):Rheumatoid ArthritisLast Updated:January 14, 2016Completed
Condition(s):Mouth Diseases; Renal Insufficiency, ChronicLast Updated:August 31, 2015Completed
Condition(s):Rheumatoid Arthritis; Parkinson Disease; HealthyLast Updated:January 29, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.